🔎 Trials Near Me

Início › Câncer de Próstata › Arkansas

Ensaios clínicos de Câncer de Próstata em Arkansas

12 estudos para Câncer de Próstata estão buscando participantes em locais em Arkansas.

Cidades em Arkansas

Texto oficial do estudo (Inglês)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mercy Hospital Fort Smith, Fort Smith
  • CARTI Cancer Center, Little Rock
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

  • Research Site, Fayetteville
RecrutandoFase 1/2
Idades de 18 a 130 · Homens · Atualizado em 25 de set. de 2026 · NCT07181161

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  • Highlands Oncology Group, PA, Fayetteville
  • Highlands Oncology Group, PA, Rogers
  • Highlands Oncology Group, PA, Springdale
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 24 de set. de 2026 · NCT07028853

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • Arkansas Urology Research Center, LLC, Little Rock
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 11 de set. de 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • University of Arkansas for Medical Sciences, Little Rock
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 10 de set. de 2026 · NCT05946213

Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)

  • University of Arkansas for Medical Sciences, Little Rock
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 8 de set. de 2026 · NCT07224009

AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions

  • University of Arkansas for Medical Sciences, Little Rock
Recrutando
Idades 40 e acima · Homens · Atualizado em 19 de ago. de 2026 · NCT07231627

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Mercy Hospital Fort Smith, Fort Smith
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 19 de ago. de 2026 · NCT04423211

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • Proton Center of Arkansas, Little Rock
Recrutando
Idades 18 e acima · Homens · Atualizado em 17 de jun. de 2026 · NCT00969111

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

  • Highlands Oncology Group - Fayetteville, Fayetteville
  • Highlands Oncology Group - Rogers, Rogers
  • Highlands Oncology Group, Springdale
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 22 de jan. de 2026 · NCT06470243

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Little Rock
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • University of Arkansas for Medical Sciences, Little Rock
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 11 de set. de 2025 · NCT03678025

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.